An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1197-1205

  Holmes, Alison ^a,b,c,d   Nolan, Rathel ^a,b,c   Taylor, Rebecca ^a,b,c   Finley, Richard ^a,b,c   Riley, Margaret ^a,b,c   Jiang, Ru zhang ^a,b,c   Steinbach, Suzanne ^a,b,c   Goldstein, Richard ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BURKHOLDERIA CEPACIA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYLOGENY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RIBOTYPING;

ADOLESCENT; ADULT; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE OUTBREAKS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; HOSPITALIZATION; HUMANS; MALE; MISSISSIPPI; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RESTRICTION MAPPING; RISK FACTORS;

EID: 0032969849     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314699     Document Type: Article

References (36)

1. 1. Burkholder W. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950;40:115-8.
2. 2. Tablan O, Chorba T, Schidlow D, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985;107:382-7.
3. 3. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-10.
4. 4. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996;143:1007-17.
5. 5. Hearst J, Elliott K. Identifying the killer in cystic fibrosis. Nat Med 1995;1: 626-7.
6. 6. Goldstein R, Sun L, Jiang RZ, Sajjan U, Forstner J, Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol 1995;177:1039-52.
7. 7. Sun L, Jiang RZ, Steinbach S, et al. The emergence of a highly transmissible lineage of cbl' Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1995;1:661-6.
8. 8. Steinbach S, Sun L, Jiang R, et al. Transmissibility of Pseudomonas cepacia infections in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994;331:981-7.
9. 9. Govan J, Brown P, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
10. 10. LiPuma J, Dasen S, Nielson D, Stern R, Stull T. Person-to-person transmission of P. cepacia between patients with cystic fibrosis. Lancet 1990; 336:1094-6.
11. 11. Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN. DNA finger-printing by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 1991;29:648-9.
12. 12. Pegues D, Carson L, Anderson R, et al. Outbreak of Pseudomonas cepacia in oncology patients. Clin Infect Dis 1993;16:407-14.
13. 13. Goldmann D, Klinger J. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr 1986;108:806-12.
14. 14. Carson L, Table O, Cassock L, Jars W, Favor M, Bland L. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol 1988;26:2096-100.
15. 15. Govan J, Hughes J, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996;45:395-407.
16. 16. Nelson J, Doherty C, Brown P, Greening A, Kauffman M, Govan J. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 1991;338:1525.
17. 17. Burdge D, Nakielna E, Noble M. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993;14:127-30.
18. 18. Rabkin C, Jarvis W, Anderson R, Stull T, Woods D. P. cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 1989;11:600-7.
19. 19. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985;39:783-91.
20. 20. National nosocomial infections surveillance system manual, USA. Atlanta: Centers for Disease Control, 1988.
21. 21. Shwachman H, Kulczycki L Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Children 1958;96:8-15.
22. 22. LiPuma J, Marks-Austin K, Holsclaw D, Winnie G, Gilligan P, Stull T. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J 1994;13:716-9.
23. 23. LiPuma J, Mortensen J, Dasen S, Stull T. Ribotype analysis of P. cepacia from cystic fibrosis treatment centers. J Pediatr 1988;113:859-62.
24. 24. Mahenthiralingam E, Campbell M, Henry D, Speert D. Typing of Pseudomonas aeruginosa and Burkholderia cepacia isolates from cystic fibrosis patients using random amplified polymorphic DNA [abstract 257]. Pediatr Pulmonol Suppl 1994;18(Suppl 10):250.
25. 25. Mahenthiralingum E, Cambell M, Henry D, Speert D. Distribution of Burkholderia cepacia RAPD types. Slide no. 19. Programs and abstracts: eighth annual North American Cystic Fibrosis Conference (Dallas). Bethesda, MD: Cystic Fibrosis Foundation, 1994.
26. 26. Johnson W, Tyler S, Rozee K. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994;32:924-30.
27. 27. Hamill R, Houston E, Georghiou P, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995; 122:762-6.
28. 28. Barth A, Pitt T. Auxotrophy of Burkholderi (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol 1995;33:2192-4.
29. 29. Strickberger MW. Genetics. New York: Macmillan, 1968.
30. 30. Smith JM, Smith NH, O'Rourke M, Spratt BG. How clonal are bacteria? Proc Natl Acad Sci USA 1993;90:4384-8.
31. 31. Wise M, Shimkets L, McArthur J. Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl Environ Microbiol 1995;61: 1791-8.
32. 32. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 1998;4:221-7.
33. 33. Cheng H, Lessie T. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol 1994;176:4034-2.
34. 34. Rodley P, Romling U, Tummler B. A physical map of the Burkholderia cepacia type strain. Mol Microbiol 1995;17:57-67.
35. 35. Holloway B. Genetics for all bacteria. Annu Rev Microbiol 1993;47:659-84.
36. 36. Centers for Disease Control and Prevention. Draft guideline for isolation precautions in hospitals; notice. Fed Register 1994;59:55564-8.